Riggs Asset Management’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-33
Closed -$22 391
2022
Q4
$22 Hold
33
﹤0.01% 329
2022
Q3
$0 Hold
33
﹤0.01% 358
2022
Q2
$0 Hold
33
﹤0.01% 348
2022
Q1
$0 Hold
33
﹤0.01% 354
2021
Q4
$0 Hold
33
﹤0.01% 344
2021
Q3
$0 Hold
33
﹤0.01% 333
2021
Q2
$0 Hold
33
﹤0.01% 333
2021
Q1
$0 Hold
33
﹤0.01% 308
2020
Q4
$0 Buy
+33
New +$33 ﹤0.01% 305
2020
Q3
Sell
-33
Closed 288
2020
Q2
$0 Hold
33
﹤0.01% 296
2020
Q1
$0 Hold
33
﹤0.01% 308
2019
Q4
$0 Hold
33
﹤0.01% 310
2019
Q3
$0 Hold
33
﹤0.01% 277
2019
Q2
$0 Hold
33
﹤0.01% 276
2019
Q1
$0 Hold
33
﹤0.01% 271
2018
Q4
$0 Hold
33
﹤0.01% 260
2018
Q3
$0 Hold
33
﹤0.01% 269
2018
Q2
$0 Buy
+33
New +$198 ﹤0.01% 282

Other funds holding TMDI

Riggs Asset Management's TMDI Position: Q1 2023 in Review

Riggs Asset Management sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 33 shares — an estimated $22 sold.

Riggs Asset Management first reported a position in TMDI in Q2 2018 and held it in 18 quarters. The position peaked at $22 in Q4 2022. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • Riggs Asset Management reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Riggs Asset Management sold 33 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $22.
  • Riggs Asset Management first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2018 and held it in 18 quarters.
  • Riggs Asset Management's Titan Medical Inc. Ordinary Shares position peaked at $22 in Q4 2022.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on Riggs Asset Management's 13F filing for Q1 2023, filed 9 May 2023.